A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report.

Hikmettullah BatgiMehmet Sinan DalAlparslan MerdinMerih Kızıl ÇakarTuğçe Nur YiğenoğluFevzi Altuntaş

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Risk of developing ischemic colitis should be kept in mind in patients receiving lenalidomide which should be discontinued in cases with severe bloody diarrhea of unknown origin.

Keyphrases

replacement therapy
multiple myeloma
case report
ischemia reperfusion injury
newly diagnosed
stem cell transplantation
ulcerative colitis
early onset
irritable bowel syndrome
blood brain barrier